Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 321-326 , September 2002

Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: Neutrophil–endothelial cell adhesion and surface expression of endothelial adhesion molecules

Received 17 December 2001 ,Revised 25 March 2002 ,Accepted 26 March 2002.

References 

  1. Burns AR, Bowden RA, Abe Y, Walker DC, Simon SI, Entman ML, et al. P-selectin mediates neutrophil adhesion to endothelial cell borders. Journal of Leukocyte Biology. 1999;65:299–306
  2. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105–111
  3. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte–endothelial cell adhesion. Journal of Leukocyte Biology. 1994;55:662–675
  4. Greene D. The pathogenesis and prevention of diabetic neuropathy and nephropathy. Metabolism. 1988;37:25–29
  5. Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and perfusion of intestine. Methods in Enzymology. 1990;186:729–742
  6. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126
  7. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. Journal of Clinical Investigation. 1995;95:1262–1270
  8. Lawrence MB, Mclntire LV, Eskin SG. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood. 1987;70:1284–1290
  9. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859–873
  10. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541–554
  11. Miyamoto S, Sawada M, Kajiwara I, Ishidou M, Murakami K, Sakaguchi K, et al. Biological characterization of ONO-3335 (the fourth report). Gendai Iryou. 1986;18:98–108Japanese
  12. Mizuno K, Kato N, Makino M, Suzuki T, Sindo M. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor, fidarestat leads to improvement of diabetic neuropathy. Journal of Diabetes Complications. 1999;13:141–150
  13. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Biological Chemistry. 2001;5:88–97
  14. Okayama N, Coe L, Oshima T, Itoh M, Alexander JS. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells. Microvascular Research. 1999;57:63–74
  15. Okayama N, Ichikawa H, Coe L, Itoh M, Alexander JS. Exogenous N.O. enhances hydrogen peroxide-mediated neutrophil adherence to cultured endothelial cells. American Journal of Physiology. 1998;274:L820–L826
  16. Okuda Y, Kawashima K, Suzuki S, Asakura Y, Asano M, Tsurumaru K, et al. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sciences. 1997;60:53–56
  17. Omi, H., Okayama, N., Shimizu, M., Okouchi, M., Ito, S., Fukutomi, T., & Itoh, M. (in press). Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effects of antidiabetic medicines. Journal of Diabetes Complications.
  18. Ridker PM. High-sensitivity c-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  19. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of c-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–733
  20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine. 1997;336:973–979
  21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425–428
  22. Ruoslahti E. Integrins. Journal of Clinical Investigation. 1991;87:1–5
  23. Smith CW. Endothelial adhesion molecules and their role in inflammation. Canadian Journal of Physiology and Pharmacology. 1993;71:76–87
  24. Suzuki N, Svensson K, Eriksson UJ. High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia. 1996;39:401–411
  25. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  26. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2207–2212

PII: S1056-8727(02)00178-2

Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 321-326 , September 2002

Article Tools

* Image Usage & Resolution